The Frontier Psychiatrists alternatives: newsletters like it

SubstackSeveral times a week · last post 12 days ago

From recent posts: Unreported Truths publishes investigative journalism covering public health policy, legal litigation, and political analysis for an audience interested in evidence-based reporting. The publication mixes in-depth…

Likely audience: public health professionals

1 shared topic

SubstackWeekly · last post 9 days ago

An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics

Likely audience: Healthcare policy makers

1 shared topic

SubstackWeekly · last post 10 days ago

Clear, evidence-based writing that helps you make better decisions about health.

Likely audience: Health-conscious individuals

1 shared topic

SubstackWeekly · last post 11 days ago

From recent posts: Dr Paddy Barrett publishes a weekly newsletter blending clinical science on cardiovascular and cognitive health with personal lifestyle essays on mindfulness and longevity. The publication covers topics ranging from…

Likely audience: Cardiologists and lipid specialists

1 shared topic

SubstackSeveral times a week · last post 9 days ago

Independent science and medical journalism

Likely audience: clinical researchers

1 shared topic

SubstackEvery two weeks · last post 10 days ago

From recent posts: Repurposed Drugs: Powers & Possibilities publishes data-driven articles on oncology, longevity, and clinical trials focusing on repurposed medications and natural agents for cancer treatment and detoxification. The…

Likely audience: Public health officials

1 shared topic

SubstackEvery two weeks · last post 35 days ago

Thought Leader reveals the issues, strategies and techniques that transform professionals into the Voice of Authority in their workplace, industry, or profession.

Likely audience: Medical professionals and neurosurgeons

1 shared topic

SubstackWeekly · last post 12 days ago

Subscribe for updates, and bold ideas from Infinita City — The City That Never Dies

Likely audience: biotech founders

1 shared topic

SubstackEvery two weeks · last post 10 days ago

Institutional investment intelligence on women’s health, Healthcare AI and the capital shaping the future of healthcare.

Likely audience: healthcare investors

1 shared topic

SubstackWeekly · last post 13 days ago

From recent posts: Decoding Bio publishes weekly newsletters focusing on specific themes like cell lineage tracing, protein design, and genomic mining, blending primary research summaries with funding news and investor event coverage. The…

Likely audience: Bioinformatics researchers

1 shared topic

SubstackMonthly or less · last post 47 days ago

Tracing the steps towards scientific progress.

Likely audience: Healthcare researchers

1 shared topic

SubstackWeekly · last post 15 days ago

What does the future hold for us in the "century of biotech"?

Likely audience: Venture capitalists

1 shared topic

SubstackEvery two weeks · last post Sep 11, 2026

From recent posts: This newsletter publishes in-depth investigative reports on public health policy, environmental hazards, and vaccine controversies, specifically targeting readers interested in critical analyses of government actions…

Likely audience: Environmental health researchers

1 shared topic

SubstackMonthly or less · last post 51 days ago

essays about biology and ml, written for and by owls

Likely audience: Neuroscience researchers

1 shared topic

SubstackSeveral times a week · last post 8 days ago

Track the women’s health market. FutureFemHealth covers the capital, companies, research and policy shaping the sector - with independent analysis of what matters and where the market is going.

Likely audience: Women's health investors

1 shared topic

SubstackWeekly · last post 8 days ago

From recent posts: Gil Carvalho, MD PhD publishes science-backed articles on nutrition, cardiovascular disease, and clinical trials for readers seeking evidence-based health information.

Likely audience: health-conscious consumers

1 shared topic

Substacklast post Jul 28, 2026

Don't Die

Likely audience: female health enthusiasts

1 shared topic

SubstackSeveral times a week · last post 12 days ago

From recent posts: The FDA Group's Insider Newsletter publishes biweekly regulatory updates, compliance case studies, and expert interviews for life science professionals navigating FDA guidance, quality audits, and therapeutic approvals…

Likely audience: Regulatory affairs professionals

1 shared topic

SubstackSeveral times a week · last post 12 days ago

From recent posts: Ian Brighthope's Substack publishes opinion pieces and podcast summaries focused on vaccine safety, national sovereignty, and alternative medical treatments for chronic illness. The content primarily targets an…

Likely audience: Journalists and media professionals

1 shared topic

SubstackEvery two weeks · last post 11 days ago

My personal Substack

Likely audience: health-conscious readers

1 shared topic

SubstackEvery two weeks · last post 8 days ago

From recent posts: The Good Science Project publishes policy analysis on NIH reform, federal regulatory friction, and research integrity for scientists and policymakers. It mixes investigative articles on funding mechanisms with event…

Likely audience: Biomedical researchers

1 shared topic

SubstackMonthly or less · last post 19 days ago

TMC Journal Watch is an academic forum dedicated to the critical appraisal of high impact medical literature across hematology, oncology, infectious diseases, and allied specialties.

Likely audience: Medical researchers

1 shared topic

SubstackSeveral times a week · last post 11 days ago

Bloated, exhausted, told it's "normal"? I'll teach you a different lens on your health — then the protocols and testing that actually work. MD • Gut Health Expert • Founder, Happy Gut Life • Author: Happy Gut, The…

Likely audience: gut health enthusiasts

1 shared topic

SubstackWeekly · last post 10 days ago

The latest research and information on GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, Zepbound , etc) and their effects on type 2 diabetes, weight loss, and heart disease.

Likely audience: Pharmacists

1 shared topic